FOAMIX PHARMACEUTICALS LTD's ticker is FOMX and the CUSIP is M46135105. A total of 69 filers reported holding FOAMIX PHARMACEUTICALS LTD in Q1 2017. The put-call ratio across all filers is 0.15 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2019 | $349,000 | +20.3% | 104,927 | +9.9% | 0.00% | – |
| Q3 2019 | $290,000 | +119.7% | 95,491 | +72.3% | 0.00% | – |
| Q2 2019 | $132,000 | -11.4% | 55,432 | +39.8% | 0.00% | – |
| Q1 2019 | $149,000 | +282.1% | 39,645 | +263.2% | 0.00% | – |
| Q4 2018 | $39,000 | -61.8% | 10,915 | -38.7% | 0.00% | – |
| Q3 2018 | $102,000 | +410.0% | 17,797 | +355.0% | 0.00% | – |
| Q2 2018 | $20,000 | -55.6% | 3,911 | -55.1% | 0.00% | – |
| Q1 2018 | $45,000 | -61.9% | 8,710 | -55.6% | 0.00% | – |
| Q4 2017 | $118,000 | +19.2% | 19,627 | +10.0% | 0.00% | – |
| Q3 2017 | $99,000 | +110.6% | 17,850 | +76.5% | 0.00% | – |
| Q2 2017 | $47,000 | +161.1% | 10,116 | +185.5% | 0.00% | – |
| Q1 2017 | $18,000 | -53.8% | 3,543 | +0.7% | 0.00% | – |
| Q4 2016 | $39,000 | +34.5% | 3,518 | +13.3% | 0.00% | – |
| Q3 2016 | $29,000 | -63.3% | 3,104 | -74.9% | 0.00% | – |
| Q2 2016 | $79,000 | +79.5% | 12,381 | +127.1% | 0.00% | – |
| Q4 2015 | $44,000 | +4300.0% | 5,452 | +6715.0% | 0.00% | – |
| Q3 2015 | $1,000 | -83.3% | 80 | -87.1% | 0.00% | – |
| Q2 2015 | $6,000 | – | 619 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| GREAT POINT PARTNERS LLC | 4,781,708 | $24,530,000,000 | 3.64% |
| Opaleye Management Inc. | 950,000 | $4,873,000 | 1.39% |
| DSC Advisors, L.P. | 1,187,604 | $6,092,000 | 1.28% |
| DAFNA Capital Management LLC | 335,500 | $1,721,000 | 0.84% |
| Vivo Capital, LLC | 855,000 | $4,386,000 | 0.62% |
| Stonepine Capital Management, LLC | 129,756 | $666,000 | 0.36% |
| Eversept Partners, LP | 107,500 | $551,475 | 0.26% |
| Tekla Capital Management LLC | 930,398 | $4,773,000 | 0.19% |
| Perceptive Advisors | 1,117,324 | $5,732,000 | 0.16% |
| Crestline Management, LP | 217,670 | $1,117,000 | 0.14% |